Loading…
Loading…
Tender ID
Tender Value
Refer Docs
Closing Date
4 Mar 2026, 11:30 amClosed
Single Packet
Normal Tender
No
Not Applicable
Itemwise/Consigneewise
Lowest to Highest
CONSIGNEE
Not Applicable
90 days
Expenditure
General
LP
1 condition · 1 needing a document upload
The bidder should have a valid drug license to participate in the bid. Drug License to be submitted along with the offer
15 conditions · 3 needing a document upload
Make/Brand, Guarantee/Warranty of the offered products to be submitted along with the offer
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
Consignee
The bidders should upload Annexure - I&I(A) duly sealaed and signed along with the bid otherwise offer will be rejected
1 condition
The materials are to be delivered within the proposed DP at site only
1 location across Assam · 3,500 Numbers total
Supply of medical item as per schedule of requirements
LD265157~NFR
LD265157
Limited - Indigenous
Goods
Assam
₹0
Exempted
4 Mar 2026
25 Feb 2026
1 item · 3,500 Numbers total
DAPAGLIFLOZIN 10MG TAB (FORXIGA 10 OR SIMILAR) [ Warranty Period: 30 Months after t he date of delivery ] ]
| Delivery Location | State | Quantity |
|---|---|---|
| CMS/LMG, NFR | Assam | 3500.00 Numbers |
| Total | 3,500 Numbers | |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
5699533.pdf
ATTACHMENT
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .